This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Why I Sold Berkshire Hathaway

Succession Brings Delegation, Diluted Returns

By all counts, Buffett is a clear-thinking, spry 81-year-old. But, given actuarial tables, his life expectancy is 92 to 93 years of age. Buffett recognizes the need to delegate investment and operating responsibilities in the passage of time. David Sokol was a big mistake, and I (and many) gave him a mulligan.

Buffett has already hired two co-investment managers, Todd Combs and Ted Weschler, to help him with Berkshire's large portfolio. Will they do as well as Buffett? Probably not, as they are mere mortals, and with the benefit of hindsight and history, Buffett was a true investing immortal! What is almost certain is that Buffett's old black magic will not be easily duplicated by his appointees.

Whitney Tilson expresses sensible reservations on Buffett's replacements:

Being offered investment opportunities on terms/prices not available to anyone else also applies to buying companies outright. There's a high degree of prestige in selling one's business to Buffett. For example, the owners of Iscar could surely have gotten a higher price had they taken the business public or sold it to an LBO firm.... Buffett's Rolodex is unrivaled, so he gets calls (and can make calls that get returned) that his successors might not.

In the next several years, a CEO will likely be named. Again, some more balanced views from Whitney:

Most of the 75-plus managers of Berkshire's operating subsidiaries are wealthy and don't need to work, but nevertheless work extremely hard and almost never leave thanks to Buffett's "halo" and superb managerial skills. Will this remain the case under his successors...? Buffett's reputation is unrivaled, so he is offered deals (such at the recent $5 billion investment in BofA) on terms that are not offered to any other investor -- and might not be offered to his successors.

Buyback Provides a Floor, but My Issue Is Potential Upside

In late September, Berkshire announced a buyback "no higher than a 10% premium over the then-current book value of the shares. In the opinion of our Board and management, the underlying businesses of Berkshire are worth considerably more than this amount...." There is no time limit and cap in terms of amount of the buyback. Based on quarter-end book value, the company's buyback will be no higher than $107,000 a share, or about 5% less than the current price. It is important to note that there is no guarantee that when the shares reach that level that Berkshire will go all-in -- one would think that they would not, so the floor is lower than $107,000; let's call it $100,000 a share). Nevertheless, the buyback creates something of a floor to the shares (probably $100,000-$107,000 a share) but does little to provide upside to the share price.

Size Constraints, Buffett's Age Limit Upside

In a recent presentation, Whitney Tilson concluded that Berkshire Hathaway's intrinsic value was about $170,000 a share. Whitney concludes that against a closing yesterday of about $114,000 a share, Berkshire is dramatically undervalued and is at a "multi-decade low" relative to its intrinsic value calculation. In support of the $170,000-per-share figure, Whitney takes the investments per share of $95,500 and adds that amount to 10x the pretax and non-investment earnings of approximately $7.2 billion, which equates to nearly 15x non-investment after-tax profits. With its core business growing at about 5% in 2012 and with another $7 billion of cash buildup in 12 months, Whitney sees the intrinsic value rising to $187,000 a year out, representing a near-40% undervaluation based on Berkshire's price today.
2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BAC $16.94 -0.53%
BRK.A $205,500.01 -0.21%
BRK.B $136.89 -0.36%
GS $208.04 -0.55%
GE $26.31 -1.76%

Markets

DOW 17,683.58 -46.53 -0.26%
S&P 500 2,068.76 -8.02 -0.39%
NASDAQ 4,991.94 -17.2740 -0.34%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs